Thank You for Attending ACPE2024 in Tokyo

Dear Colleagues,

On behalf of the organizing committee, I would like to extend our heartfelt thanks for attending the ACPE2024 Conference in Tokyo.

Your participation and engagement were invaluable in making this event a success. We hope the conference provided you with insightful knowledge, meaningful connections, and opportunities to exchange ideas with colleagues from around the globe.

It was a pleasure to host you, and we look forward to welcoming you again at future ACPE events. If you have any feedback or suggestions, please feel free to share them with us—we always strive to improve and make our conferences even more impactful.

Thank you once again for being a part of ACPE2024.

Sincerely,

ACPE2024 Organising Committee

Welcome from ACPE2024 Local Host Committee Chair

Dear Colleagues,

I am writing on behalf of the host committee to extend a heartfelt invitation to you to attend the 16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in Tokyo, Japan.

This conference is designed to enrich scientific dialogues and includes a variety of educational programs, opportunities for oral and poster presentations, and symposiums. These elements are integral in advancing health through the field of pharmacoepidemiology. We are eagerly anticipating your presence in Tokyo and look forward to the valuable contributions you will bring to our discussions.

Sincerely,

Prof Nobuhiro Ooba
ACPE Chair
Nihon University, School of Pharmacy, Chiba, Japan

Welcome from ACPE2024 Program Committee Chair

Dear Colleagues,

Welcome to the 16th Asian Conference on Pharmacoepidemiology here in Tokyo! This conference presents a unique opportunity to explore new methodologies and approaches in pharmacoepidemiology, with a focus on the diverse healthcare landscapes and research across Asia. We will also be examining key topics such as the use of real-world evidence in regulatory decision-making, the role of AI and machine learning in the field, COVID-19 and other infectious diseases, and the safety of medications across various medical fields. I am confident that these sessions will provide valuable insights and foster collaboration both within our region and beyond, reflecting the significant advancements in pharmacoepidemiology studies in Asia over recent years.

I would like to sincerely thank our speakers, presenters, committee members, the ISPE and the JSPE, and everyone involved in the submissions and reviews of the program. Your contributions have made this conference possible and underscore the growing strength of pharmacoepidemiology in Asia. Thank you for being a part of ACPE 2024, and I look forward to our time together.

Sincerely,

Hiraku Kumamaru, MD 
ACPE Program Committee Chair
Associate Professor, Healthcare Quality Assessment
University of Tokyo

Welcome from ACPE International Steering Committee (ISC) Chair

As Chair of the ACPE ISC at the International Society of Pharmacoepidemiology (ISPE),  I am delighted to welcome you to ACPE 2024 in Tokyo, Japan. This year’s conference marks a historic milestone for ACPE, with the largest number of abstracts ever submitted in our 16 conferences hosted across the Asia Pacific. ACPE was founded over 20 years ago by pioneering pharmacoepidemiologists in the Asia Pacific who recognized the need and potential for growth in this field in our region.

Over the past 15 conferences, we have witnessed significant advancements in pharmacoepidemiology, including the development of data resources and infrastructure, the rise of a new generation of pharmacoepidemiologists, impactful evidence informing medical and pharmacy practices and policies, and strong collaborations among academia, industry, and governments across the Asia Pacific.

We look forward to continuing this momentum together in Tokyo.

Sincerely,

Soko Setoguchi, MD, DrPH, FISPE
ACPE ISC Chair
Professor of Medicine and Epidemiology
Rutgers University

Welcome to ACPE 2024 from the ISPE Immediate Past President

On behalf of the International Society of Pharmacoepidemiology (ISPE), I warmly welcome you to the Asian Conference in Pharmacoepidemiology in Tokyo, hosted in collaboration with the Japanese Society of Pharmacoepidemiology.

This meeting promises insightful discussions, collaborative opportunities, and innovative insights into pharmacoepidemiology against Tokyo’s vibrant backdrop. Our shared commitment underscores the importance of international collaboration in addressing health challenges.

Join us for dynamic exchanges, keynote presentations, workshops, and networking sessions that contribute to advancing our field. Beyond the scientific program, explore Tokyo’s cultural heritage and hospitality.

Welcome to Tokyo and to the Asian Conference in Pharmacoepidemiology!

With kindest regards,

Lisa G. Pont, FISPE
Associate Professor & Team Lead Medicines Use Research in Aged Care (MURAC)
University of Technology Sydney

Hosted by

Supported by